Loading institutional data...
Loading institutional data...
Institutional ownership roughly stable: +0.04% change quarter-over-quarter.
Data as of Q1 2026
Loading snapshot...
Loading financials...
Loading valuation...
Loading quality & risk...
Loading dividends & returns...
Loading capital allocation...
Loading debt & leverage...
Loading performance...
Loading peer comparison...
Loading ownership map...
Loading crowding analysis...
Loading conviction analysis...
Loading buy/sell flow...
Loading ownership trends...
Loading top holders...
Loading top holders...
Total shares institutions bought (green) vs sold (red) each quarter across all holders.
Inferred from quarter-over-quarter change in each fund's 13F position (new stakes count as buys, exits as sells). Not tick-level trades.
Solve the discounted cash flow backwards, then stress-test the assumptions.
This company doesn't have positive free cash flow, so a reverse DCF can't be run.
Total return (dividends reinvested) vs the market, from quarter-end prices.
Above 0 = ahead of the S&P 500 since the window start; below 0 = behind. Rising means it's pulling ahead.
How far the stock fell below its prior peak. Deeper, longer drawdowns = a rougher ride to the same return.
Quarter-end, dividend-adjusted (total return). Beta & volatility from quarterly returns (annualized). Benchmark is the S&P 500 (SPY total return). Annual returns compound the quarters ending in each calendar year; the first and last years in a window may be partial. Past performance doesn't predict future results.
Top 12 institutional holders — bubble size is position value, color is the move since last quarter. Hover any holder for detail.
Drag any bubble to rearrange · size = dollar value of the position
Is the value real, and is the business safe? Academic scores + earnings quality + solvency, from SEC filings.
3/8 of the 9 checks — 1 couldn't be scored (see above), so the score is out of the 8 with data.
Safe > 2.99 · grey 1.81–2.99 · distress < 1.81
Needs granular two-year detail (receivables, PP&E, D&A, SG&A) — not fully reported.
Cash-conversion data unavailable. Lower/negative accruals = higher quality (Sloan).
Interest coverage is thin — monitor; leverage rising year-over-year.
F-Score (0–9 fundamental momentum), Altman Z (distress risk), and Beneish M (earnings-manipulation screen) are academic models computed from the SEC filings. Screens and context — educational, not recommendations.
What the company returns to shareholders — and whether it's covered by cash.
No dividend to cover. Last year: $0 dividends + $3M buybacks = $3M returned on -$21M FCF.
Yields use the latest fiscal-year dividends/buybacks over current market cap. Dividends and buybacks from the SEC cash-flow statement; payout coverage vs net income and free cash flow. Educational — not a recommendation.
How management deployed cash over 7 years — and what it earned on reinvestment.
A reinvestment story — most cash went back into growth rather than to shareholders.
Operating income fell despite reinvestment — a warning on capital productivity. Current ROIC on all capital: -54%. Rough measure (includes maintenance capex).
Cash uses aggregated from the SEC cash-flow statement over 7 fiscal years. "Return on reinvestment" is a rough proxy — operating-income change ÷ cumulative CapEx + M&A — and includes maintenance capex. Educational — not a recommendation.
How much the company owes, how it's trended, and how comfortably it's serviced.
Cash of $8M is below the $35M due within a year — relies on refinancing or operating cash flow. Scheduled principal only (excludes interest & revolver draws). As of 2026-03-31 (10-Q).
Insufficient EBITDA/debt history.
Green ≤ 1.5× · amber ≤ 3× · red > 3× (leverage relative to cash earnings).
Thin coverage — earnings barely cover interest. Effective rate ~9.8% on $58M of debt.
Cash of $8M is below short-term debt of $31M — relies on refinancing/operations.
Mostly short-term debt (balance-sheet current vs non-current split). See the maturity ladder above for the year-by-year repayment schedule.
Debt, cash, interest and equity from the SEC balance sheet & income statement. Effective rate = interest ÷ average debt. Maturity ladder from the SEC long-term-debt repayment schedule. Educational — not a recommendation.
EOD close · as of 2026-08-05
No standout strengths flagged.
Where each multiple sits in its own 5-yr range · 20th pct blended
Dot = today · shaded = middle 50% · line = median. Lower percentile = cheaper vs its own 5-yr history.
Is the profit real, and how strong is the balance sheet?
FY2025 · every deduction from revenue to net income
DuPont — the three levers
Watch the leverage lever — a chunk of ROE comes from the balance sheet.
What the company owes vs. what it holds
Year-by-year maturities aren't in SEC companyfacts (footnote-only), so this shows the debt/cash structure and net leverage instead.
Latest year: profit growth vs revenue growth
Profit and sales moved in opposite directions this year.
Each line as % of revenue — the trend in color
| % of revenue | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|
| R&D | 6.6 | 5.5 | 6.4 | 8.3 | 4.9 | 5.7 | 5.8 |
| SG&A | 27.5 | 25.8 | 28.3 | 34.2 | 33.9 | 30.9 | 27.2 |
| Operating Income | -12.7 | 3.8 | -6.2 | -35.2 | -19.5 | -12.4 | -25.8 |
| Income Tax | -0.1 | 0.3 | -0.7 | 0.8 | 0.7 | 0.3 | 0.2 |
| Net Income | -11.7 | 3.2 | 6.4 | -61.7 | -38.4 | -5.3 | -31.2 |
Green = margin-favorable vs the row's own range · red = unfavorable.
The metrics that matter, over time
A 30-second read on BZFDW: price, valuation, headline fundamentals, and an auto-generated scorecard from SEC filings. Flags are rule-based signals, not recommendations.
EOD close · as of 2026-08-05 · 45d old
How a revenue dollar becomes profit — FY2025
Each value shows its share of revenue below it (common-size).
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Revenue | $185.3M 100.0% | $189.9M 100.0% | $230.4M 100.0% | $325.8M 100.0% | $383.8M 100.0% | $321.3M 100.0% | $317.9M 100.0% |
| Research & Development | $10.8M 5.8% | $10.9M 5.7% | $11.2M 4.9% | $27.1M 8.3% | $24.7M 6.4% | $17.7M 5.5% | $21.1M 6.6% |
| Selling, General & Admin | $50.4M 27.2% | $58.6M 30.9% | $78.0M 33.9% | $111.4M 34.2% | $108.7M 28.3% | $83.1M 25.8% | $87.4M 27.5% |
| Total Operating Expenses | $233.2M 125.8% | $213.4M 112.4% | $275.3M 119.5% | $440.3M 135.2% | $407.7M 106.2% | $309.2M 96.2% | $358.2M 112.7% |
| Operating Income | -$47.9M -25.8% | -$23.5M -12.4% | -$44.8M -19.5% | -$114.6M -35.2% | -$23.9M -6.2% | $12.1M 3.8% | -$40.3M -12.7% |
| Interest Expense | $5.7M 3.1% | $6.8M 3.6% | $16.1M 7.0% | $15.6M 4.8% | $2.5M 0.7% | — | — |
| Other Income (Expense), net | -$4.9M -2.6% | -$1.6M -0.8% | -$3.0M -1.3% | -$3.1M -0.9% | -$4.0M -1.0% | $882K 0.3% | $1.6M 0.5% |
| Pretax Income | -$56.9M -30.7% | -$33.3M -17.5% | -$54.1M -23.5% | -$114.8M -35.2% | $1.1M 0.3% | $12.1M 3.8% | -$37.3M -11.7% |
| Income Tax Expense | $386K 0.2% | $662K 0.3% | $1.6M 0.7% | $2.7M 0.8% | -$2.7M -0.7% | $941K 0.3% | -$358K -0.1% |
| Net Income | -$57.7M -31.2% | -$10.1M -5.3% | -$88.6M -38.4% | -$201.0M -61.7% | $24.7M 6.4% | $10.3M 3.2% | -$37.2M -11.7% |
| Per Share | |||||||
| EPS (Basic) | $-1.53 | $-0.27 | $-2.48 | $-5.82 | $0.00 | $0.00 | $-3.15 |
| EPS (Diluted) | $-1.53 | $-0.27 | $-2.48 | $-5.82 | $-0.03 | $0.00 | $-3.15 |
| Weighted Avg Shares (Basic) | 37.8M | 37.4M | 35.8M | 34.5M | 27.0M | 11.9M | 11.8M |
| Weighted Avg Shares (Diluted) | 37.8M | 37.4M | 35.8M | 34.5M | 28.0M | 11.9M | 11.8M |
Source: SEC EDGAR XBRL filings (annual, fiscal year). Quarterly flow items are derived from cumulative filings; balance-sheet figures are as-of each period end. Ratios and margins are computed, not reported.